Skip to content

Fetal sex differentiation

The first chapter of the male development arc. From an embryo that started bipotential — anatomically the same whether 46,XX or 46,XY — the male reproductive anatomy is built over the second and third trimesters under the direction of one genetic switch (SRY) and three fetal hormones (testosterone, DHT, AMH).

Early embryos — XX and XY alike — are anatomically identical with respect to the reproductive system. Two structures are laid down in parallel, with the potential to become either male or female.

Around weeks 4–5, a ridge of tissue called the gonadal ridge (or genital ridge) forms on the medial surface of the mesonephros. It contains two ingredients:

  • Primordial germ cells — the future sperm or egg precursors. They do not originate in the gonad; they form in the yolk sac and migrate into the gonadal ridge during week 5.
  • Somatic support cells — derived from the surrounding mesoderm. These will become either Sertoli + Leydig cells (testis) or granulosa + theca cells (ovary).

The gonad has two zones — a cortex (outer) and a medulla (inner) — and the fate of the whole organ comes down to which zone develops:

  • With SRY (week 6–7, XY embryo) → the medulla becomes testis tissue, the cortex regresses → testis.
  • Without SRY (XX embryo) → the cortex becomes ovarian tissue, the medulla regresses → ovary.

Every early embryo also has both sets of internal plumbing already in place:

  • Wolffian (mesonephric) ducts — the male-pattern ducts. Will become epididymis, vas deferens, and seminal vesicles if preserved.
  • Müllerian (paramesonephric) ducts — the female-pattern ducts. Will become fallopian tubes, uterus, and upper vagina if preserved.

Which set is kept and which regresses depends on signals from the gonad — meaning the gonad’s fate dictates the duct fate, not the other way around.

The whole arrangement has a clear asymmetry: female development is the default; male development is the actively-triggered branch. Without the right signals at the right time, the gonad becomes an ovary, the Müllerian ducts persist, and the Wolffian ducts regress. The male program requires SRY, Sertoli AMH, and Leydig testosterone to all show up on schedule.

SRY (“Sex-determining Region Y”) is the genetic trigger. It is a small gene on the short arm of the Y chromosome that encodes a single transcription factor — a protein whose job is to bind DNA and switch other genes on.

What it does, mechanistically:

  1. Around weeks 6–7, SRY is briefly expressed in the somatic cells of the gonad’s medulla.
  2. SRY protein binds DNA and upregulates a second gene, SOX9.
  3. SOX9 drives the cascade that turns those cells into Sertoli cells.
  4. The newly-formed Sertoli cells organize into testis cords, recruit fetal Leydig cells from the surrounding mesenchyme, and begin producing AMH (from Sertoli) and testosterone (from Leydig).

Then SRY expression fades. It is essentially a one-time switch — a brief tap on the wheel that sets a long downstream cascade in motion. Most of what we think of as “male development” is not SRY itself but the hormonal program it hands off to.

Three consequences fall out of this architecture:

  • It is the actual sex-determining switch. Whether a fetus develops as male or female comes down to whether SRY is expressed at the right time in the right place, not to chromosome count per se.
  • It can be in the wrong place. Rare translocations move SRY onto an X chromosome, producing 46,XX individuals who develop as male — XX male syndrome (also called de la Chapelle syndrome).
  • It can fail. A 46,XY embryo with an SRY mutation develops down the default ovarian/female pathway and is born phenotypically female with non-functional streak gonads — Swyer syndrome / 46,XY complete gonadal dysgenesis.
  • Weeks 4–5 — the bipotential gonadal ridge forms; primordial germ cells migrate in from the yolk sac.
  • Weeks 6–7 — the SRY gene is briefly expressed in the medulla; the bipotential gonad commits to becoming a testis.
  • Week 8 onward — fetal Leydig cells begin producing testosterone, which drives the Wolffian ducts to become the epididymis, vas deferens, and seminal vesicles.
  • Same window — DHT (a more potent androgen made from testosterone by 5α-reductase) drives formation of the external male genitalia: penis, scrotum, and prostate.
  • Same window — Sertoli cells produce AMH (anti-Müllerian hormone), which causes the Müllerian duct system to regress. In its absence (as in 46,XX embryos) the Müllerian system persists and becomes fallopian tubes, uterus, and upper vagina.
  • Third trimester — a fetal HPG-axis burst drives the descent of the testes from the abdomen into the scrotum, and the final stretch of penile growth.
  • Testosterone — from fetal Leydig cells; masculinizes the internal duct system (Wolffian derivatives).
  • DHT — from peripheral conversion of testosterone by 5α-reductase; drives external genitalia and the prostate.
  • AMH — from fetal Sertoli cells; suppresses the Müllerian duct system.
  • Gonadotropins (hCG, then LH) — drive the fetal Leydig cells. Early on, placental hCG (which acts on the LH receptor) is the dominant signal; later, fetal pituitary LH takes over.

The third-trimester HPG burst is when things visible at birth get set up. Failures here leave externally observable markers:

  • Cryptorchidism — undescended testes; one or both fail to reach the scrotum. Common in preterm infants; persistent cryptorchidism beyond the first months of life is an early sign of severe HPG dysfunction.
  • Micropenis — penile length below the expected range for gestational age. Reflects insufficient fetal androgen action during the third trimester.

These are early clues that drive newborn endocrine workup — see HPG axis deviations.

The whole male program cascades downstream from a single brief genetic event: SRY’s expression in a bipotential gonad at weeks 6–7. Everything afterwards — testis formation, Sertoli AMH suppressing the Müllerian ducts, Leydig testosterone building the Wolffian system and (via DHT) the external genitalia, the third-trimester descent — is the hormonal consequence of that switch. By birth, the male reproductive anatomy is essentially complete, even though the function (fertility, secondary sex characteristics) is still many years away.